FAST trial, MMF vs MTX at the Review Course today Overall a big win for MTX, powered for noninferiority (bc people loved MMF) but looks like MTX won the day w/10% difference in outcomes Take home: MTX FTW per usual @RheumNow #ACR23 #ReviewCourse https://t.co/lY1V6S7X3d